Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccine Production01:23

Vaccine Production

144
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and Functional Evaluation of Cyclic Peptide-Based CAR T Cells in Tumor Models.

Bio-protocol·2026
Same author

The interplay mechanisms between gut microbiota and ferroptosis in inflammatory bowel disease.

Frontiers in immunology·2026
Same author

Pal Affects the Proliferation in Macrophages and Virulence of Brucella, and as Mucosal Adjuvants, Provides an Effective Protection to Mice Against Salmonella Enteritidis.

Current microbiology·2022
Same author

Whole-Genome Resequencing to Study Brucellosis Susceptibility in Sheep.

Frontiers in genetics·2021
Same author

Cell membrane components of Brucella melitensis play important roles in the resistance of low-level rifampicin.

PLoS neglected tropical diseases·2020
Same author

Genome-Wide Analysis of the Response of Brucella melitensis NI to Polymyxin B.

Current pharmaceutical biotechnology·2020

Related Experiment Video

Updated: May 4, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

7.5K

Research progress in live attenuated Brucella vaccine development.

Zhen Wang, Qingmin Wu1

  • 1Key Laboratory of Animal Epidemiology and Zoonosis of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. wuqm@cau.edu.cn.

Current Pharmaceutical Biotechnology
|December 31, 2013
PubMed
Summary
This summary is machine-generated.

Developing novel live attenuated vaccines is crucial for preventing and controlling brucellosis, a zoonotic disease affecting animals and humans. Current vaccines have limitations, driving research into safer and more effective alternatives.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K

Related Experiment Videos

Last Updated: May 4, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
15:29

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

7.5K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.9K

Area of Science:

  • Veterinary Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Brucellosis is a significant zoonotic disease caused by Brucella spp., leading to animal abortions and human health issues like undulant fever and meningitis.
  • Current human vaccines for brucellosis are unavailable, and existing animal vaccines have drawbacks, including potential abortion induction, lower efficacy, and higher human virulence.
  • Significant research efforts are underway to create advanced Brucella vaccines for both animal and human health.

Purpose of the Study:

  • To review and discuss current research on novel vaccine development strategies for Brucella.
  • To explore approaches for creating effective live attenuated vaccines against brucellosis.

Main Methods:

  • Review of recent scientific literature on Brucella vaccine development.
  • Analysis of different strategies for creating live attenuated Brucella vaccines.

Main Results:

  • Identification of limitations in existing Brucella vaccines.
  • Exploration of various novel approaches for live attenuated vaccine design.

Conclusions:

  • Novel live attenuated vaccines hold promise for improved brucellosis prevention and control.
  • Continued research is essential to overcome the challenges associated with current Brucella vaccines and develop safer, more effective alternatives.